Chapman, Arlene B <br/><br/>
Approaches to testing new treatments in autosomal dominant polycystic kidney disease: insights from the CRISP and HALT-PKD studies.  [electronic resource] 

 -  Clinical journal of the American Society of Nephrology : CJASN  Jul 2008 
 - 1197-204 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1555-905X 
<br/><br/><label>Standard No.: </label>10.2215/CJN.00060108  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiotensin II Type 1 Receptor Blockers--therapeutic use<br/>Angiotensin-Converting Enzyme Inhibitors--therapeutic use<br/>Antihypertensive Agents--pharmacology<br/>Blood Pressure--drug effects<br/>Clinical Trials as Topic<br/>Disease Progression<br/>Humans<br/>Kidney--drug effects<br/>Magnetic Resonance Imaging<br/>Polycystic Kidney, Autosomal Dominant--drug therapy<br/>Renin-Angiotensin System--drug effects<br/>Treatment Outcome